|
|
| | N-((S)-1-(((R)-1-Hydroxy-3-Methylbutyl)aMino)-1-oxo-3-phenylpropan-2-yl)pyrazine-2-carboxaMide Basic information |
| Product Name: | N-((S)-1-(((R)-1-Hydroxy-3-Methylbutyl)aMino)-1-oxo-3-phenylpropan-2-yl)pyrazine-2-carboxaMide | | Synonyms: | 2-PyrazinecarboxaMide, N-[(1S)-2-[[(1R)-1-hydroxy-3-Methylbutyl]aMino]-2-oxo-1-(phenylMethyl)ethyl]-;(R)-Hydroxy Des(boric Acid) BortezoMib;(N-[(1R)-1-hydroxy-3-Methylbutyl]-Nα-(pyrazin-2-ylcarbonyl)-L-phenylalaninaMide;Bortezomib Impurity 2 (SR-Isomer, Bortezomib Impurity E);SR-Isomer, Bortezomib Impurity E;Bortezomib Impurity 2 (S,R-Isomer);N-((S)-1-(((R)-1-Hydroxy-3-Methylbutyl)aMino)-1-oxo-3-phenylpropan-2-yl)pyrazine-2-carboxaMide;BortezoMib IMpurity 2 (SR-IsoMer, EP IMpurity E) | | CAS: | 289472-78-2 | | MF: | C19H24N4O3 | | MW: | 356.42 | | EINECS: | | | Product Categories: | | | Mol File: | 289472-78-2.mol |  |
| | N-((S)-1-(((R)-1-Hydroxy-3-Methylbutyl)aMino)-1-oxo-3-phenylpropan-2-yl)pyrazine-2-carboxaMide Chemical Properties |
| Boiling point | 672.0±55.0 °C(Predicted) | | density | 1.199±0.06 g/cm3(Predicted) | | storage temp. | 2-8°C | | solubility | Chloroform (Slightly), DMSO (Slightly), Methanol (Slightly) | | pka | 11.90±0.46(Predicted) | | form | Solid | | color | White to Off-White | | InChIKey | NEIDLJIPMZVISC-DOTOQJQBSA-N | | SMILES | C1(C(N[C@@H](CC2=CC=CC=C2)C(N[C@H](O)CC(C)C)=O)=O)=NC=CN=C1 |
| | N-((S)-1-(((R)-1-Hydroxy-3-Methylbutyl)aMino)-1-oxo-3-phenylpropan-2-yl)pyrazine-2-carboxaMide Usage And Synthesis |
| Uses | (R)-Hydroxy Des(boric acid) Bortezomib is an impurity in the synthesis of Bortezomib (B675700), the first proteasome inhibitor to be approved by the US FDA for multiple myeloma, a blood cancer. A reversible inhibitor of the 26S proteasome-a barrel-shaped multiprotein particle found in the nucleus and cytosol of all eukaryotic cells. Targets the ubiquitin-proteasome pathway. |
| | N-((S)-1-(((R)-1-Hydroxy-3-Methylbutyl)aMino)-1-oxo-3-phenylpropan-2-yl)pyrazine-2-carboxaMide Preparation Products And Raw materials |
|